Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
about
Drug nanocrystals: A way toward scale-upPerformance Parameters and Characterizations of Nanocrystals: A Brief ReviewTransformation of eutectic emulsion to nanosuspension fabricating with solvent evaporation and ultrasonication technique.Stability and Biological Activity Evaluation of Chlorantraniliprole Solid Nanodispersions Prepared by High Pressure HomogenizationEvaluation of Stability and Biological Activity of Solid Nanodispersion of Lambda-Cyhalothrin.Novel biodegradable polyesters. Synthesis and application as drug carriers for the preparation of raloxifene HCl loaded nanoparticles.Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaEnhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulationNitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.Characterization of ibuprofen microparticle and improvement of the dissolution.Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety.A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.Process optimization and evaluation of novel baicalin solid nanocrystalsDrug nanoparticles: formulating poorly water-soluble compounds.Recent advances in intravenous delivery of poorly water-soluble compounds.Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods.A mini review of nanosuspensions development.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension.Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement.Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties.Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design.Influence of spray drying and dispersing agent on surface and dissolution properties of griseofulvin micro and nanocrystals.New thermosensitive nanoparticles prepared by biocompatible pegylated aliphatic polyester block copolymers for local cancer treatment.Encapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti-HIV-1 activity using lentiviral particles.In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizesUnderstanding the structure and stability of paclitaxel nanocrystalsFormulation and delivery strategies of ibuprofen: Challenges and opportunities.Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan.Preparation and in-vitro evaluation of indomethacin nanoparticlesProperties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee'S Wax.The use of artificial neural networks for optimizing polydispersity index (PDI) in nanoprecipitation process of acetaminophen in microfluidic devices.Size Control in the Nanoprecipitation Process of Stable Iodine (¹²⁷I) Using Microchannel Reactor-Optimization by Artificial Neural Networks.The impact of dosing interval in a novel tandem oral dosing strategy: enhancing the exposure of low solubility drug candidates in a preclinical setting.Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology.Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.
P2860
Q26744024-93F151BE-E90E-4C4A-8E32-B8E1E4F24182Q28077580-608B1733-6A9B-4239-A9EE-A591B7945179Q30380599-1D3860FA-1D78-4B81-AA9A-06DA835D891AQ30382120-12B6707D-E575-44FC-8FA3-8C2A1D6ED3D1Q30387849-C003BB48-989A-462E-BF66-9389345FD3CAQ33487116-1D904BEC-20CC-40B7-A5B1-FA79D1BDA8CAQ33761970-8B4642EB-DA26-4D55-B6EB-B8FAA8E0D978Q34789136-6725507C-3446-4A80-971E-F5341932203BQ35577240-314E0994-7432-4F34-A734-FC84207D437DQ35577252-5EAA0D12-CFA0-494C-8216-DCF2CF388D63Q35982999-34704D21-DB83-4C29-8C38-B951CCDFC0B4Q36404933-BBFA5494-7A86-4E92-B8FC-BF7852928FC8Q36960535-DF72430F-4D03-4E83-B7F0-345FB9DC5C6DQ37042592-FEE20E60-10A0-45CB-90B3-D5DAEADCE211Q37103479-5FE8A48B-9885-4691-829E-13E0B7FA4BE6Q37109079-1BF77860-5992-4816-B9BA-1E5CA6259775Q37639306-786BABC0-D464-46C0-8A1B-DF1A5D4E37A8Q37805588-CF719E27-C844-414B-B6E5-35D1140F556AQ37970772-9D8AD6B1-2899-4F9F-8F52-8DA719243481Q38227621-97564EB5-4015-4C7B-BD89-449D1EAB5F99Q38534116-B5C83A37-B049-49FC-BFB8-4F8A2FEEF221Q38548995-BEC45707-5392-4AA3-8486-F01D82B63160Q38554933-A0E85E2D-839A-4A0C-AE70-59EF37D728BCQ39641785-2399DD3D-DA46-4D38-AA41-5B99701FD11DQ39849847-57CB2728-F2E4-4120-9D0D-20DD3BEFB00AQ40172739-B91A024B-8405-44BB-9695-8AC7DA203892Q40215796-05BE4201-C0D5-4F69-AEBC-5538AA6FC6DDQ41283296-1716BE98-B783-4138-ABF8-813B752F90AFQ41884506-AD06AE22-AF63-43E4-8894-6AFD0BA31203Q41922089-986055FE-E986-46DC-AAB1-266E67256C12Q41988160-8A61D564-AE47-424A-A27C-88D10C8A6B61Q42003875-CD0C38D7-DDB2-4983-B546-D0693A89C631Q42321619-87483142-5840-41E1-8332-52566CFDCBC9Q42383253-849EA572-217F-4D94-A56C-E027FD509F05Q42646386-1085C0B1-1B45-4D27-B6E8-A59D5665A7E5Q42704990-9964F159-7FA4-4DE5-95C1-9612AFE670E9Q42761110-221045F0-CD7A-4A5D-8845-D835455612E3Q42843043-E785F238-9561-475E-AAA4-6BDF2B50FF69Q43078099-0B07B87E-18ED-4E2B-8C79-31C2074FB527Q43273572-AE19D235-7590-4453-B805-DBDC9B9FEDCC
P2860
Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Preparation and evaluation of ...... ution of poorly soluble drugs.
@en
Preparation and evaluation of ...... ution of poorly soluble drugs.
@nl
type
label
Preparation and evaluation of ...... ution of poorly soluble drugs.
@en
Preparation and evaluation of ...... ution of poorly soluble drugs.
@nl
prefLabel
Preparation and evaluation of ...... ution of poorly soluble drugs.
@en
Preparation and evaluation of ...... ution of poorly soluble drugs.
@nl
P2093
P1476
Preparation and evaluation of ...... ution of poorly soluble drugs.
@en
P2093
P304
P356
10.1016/J.IJPHARM.2006.01.008
P407
P577
2006-02-15T00:00:00Z